NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

LUNG

Pulmonx Corp

Jul 03 • 03:59PM ET

2.78

Dollar change +0.06
Percentage change 2.21	%

Healthcare • Medical Devices • USA • NASD

Peers: DHR MDT EW ISRG SYK BSX ZBH HOLX XRAY ALGN

| Held by: VTI IWM VXF IWO VTWO SCHA VHT IWC DFAS ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.45	Insider Own	12.58%	Shs Outstand	40.25M	Perf Week	7.34%
Market Cap	111.92M	Forward P/E	-	EPS next Y	-1.39	Insider Trans	-3.25%	Shs Float	35.19M	Perf Month	-12.58%
Enterprise Value	79.91M	PEG	-	EPS next Q	-0.39	Inst Own	85.56%	Short Float	4.03%	Perf Quarter	-59.24%
Income	-57.09M	P/S	1.28	EPS this Y	-6.92%	Inst Trans	1.21%	Short Ratio	3.76	Perf Half Y	-58.57%
Sales	87.47M	P/B	1.44	EPS next Y	9.60%	ROA	-36.21%	Short Interest	1.42M	Perf YTD	-59.06%
Book/sh	1.93	P/C	1.26	EPS next 5Y	10.76%	ROE	-60.68%	52W High	9.37 -70.33%	Perf Year	-55.45%
Cash/sh	2.21	P/FCF	-	EPS past 3/5Y	-2.30% -19.80%	ROIC	-45.42%	52W Low	2.50 11.20%	Perf 3Y	-81.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.06% 20.78%	Gross Margin	73.47%	Volatility	5.88% 6.90%	Perf 5Y	-
Dividend TTM	-	EV/Sales	0.91	EPS Y/Y TTM	5.77%	Oper. Margin	-64.04%	ATR (14)	0.22	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.29	Sales Y/Y TTM	19.84%	Profit Margin	-65.27%	RSI (14)	41.83	Recom	1.57
Dividend Gr. 3/5Y	- -	Current Ratio	4.97	EPS Q/Q	-1.60%	SMA20	-2.96%	Beta	0.44	Target Price	11.31
Payout	-	Debt/Eq	0.73	Sales Q/Q	19.54%	SMA50	-17.46%	Rel Volume	0.40	Prev Close	2.72
Employees	291	LT Debt/Eq	0.62	Earnings	Apr 30 AMC	SMA200	-53.30%	Avg Volume	376.75K	Price	2.78
IPO	Oct 01, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.98% 2.29%	Trades		Volume	151,836	Change	2.21%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-10-25	Initiated	D. Boral Capital	Buy	$17
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$17 → $7.50
Jun-04-24	Initiated	Lake Street	Buy	$12
Feb-23-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$16 → $14
Sep-05-23	Initiated	Craig Hallum	Buy	$18
Feb-27-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$10 → $15
Jan-03-23	Downgrade	BofA Securities	Neutral → Underperform	$8
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$14 → $10
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$23 → $19
Mar-02-22	Resumed	BofA Securities	Neutral	$28
Dec-08-21	Upgrade	Piper Sandler	Neutral → Overweight	$45
Apr-01-21	Initiated	Citigroup	Buy	$60
Mar-25-21	Initiated	Piper Sandler	Neutral	$50
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy	$72
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Oct-26-20	Initiated	Wells Fargo	Equal Weight	$46
Oct-26-20	Initiated	Stifel	Buy	$50
Oct-26-20	Initiated	Morgan Stanley	Equal-Weight	$44
Oct-26-20	Initiated	Canaccord Genuity	Buy	$49
Oct-26-20	Initiated	BofA Securities	Buy	$50

Show Previous Ratings

May-28-25 04:05PM	Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire) +8.11%
May-03-25 11:00AM	Ford, Disney, And AMD To Report Results Next Week (Seeking Alpha)
May-01-25 04:05PM	Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference (GlobeNewswire) -21.95%
10:06AM	Q1 2025 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:18AM	Pulmonx Corp (LUNG) Q1 2025 Earnings Call Highlights: Strong International Growth Amid Domestic ... (GuruFocus.com)
08:25PM	Loading…
Apr-30-25 08:25PM	Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript (Seeking Alpha) -8.35%
06:10PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-16-25 04:05PM	Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025 (GlobeNewswire) -5.64%
06:53AM	P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar? (Zacks)
Apr-10-25 11:38AM	Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? (Zacks)
Feb-20-25 01:14PM	Q4 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents) +32.23%
02:12AM	Pulmonx Corp (LUNG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Financial ... (GuruFocus.com)
Feb-19-25 05:20PM	Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -5.01%
04:05PM	Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
04:58AM	Loading…
04:58AM	What To Expect From Pulmonx Corp (LUNG) Q4 2024 Earnings (GuruFocus.com)
Feb-13-25 04:05PM	Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day (GlobeNewswire) +5.28% -5.56%
Feb-05-25 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 (GlobeNewswire) +6.59%
Nov-21-24 09:55AM	Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? (Zacks)
Nov-20-24 04:05PM	Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-19-24 09:00AM	Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers (Business Wire)
Nov-07-24 04:05PM	Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-05-24 04:05PM	Pulmonx to Present at the Stifel 2024 Healthcare Conference (GlobeNewswire) +8.44%
09:55AM	Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know (Zacks)
Oct-31-24 07:00AM	Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... (GuruFocus.com) -7.95%
Oct-30-24 06:25PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-16-24 04:05PM	Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024 (GlobeNewswire) -5.74%
Sep-09-24 04:05PM	Pulmonx Announces Presentation of Clinical Data from the AeriSeal CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 (GlobeNewswire) +9.00%
Aug-29-24 04:05PM	Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference (GlobeNewswire)
04:05PM	Loading…
Aug-22-24 04:05PM	Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference (GlobeNewswire) +9.32%
Jul-31-24 05:50PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.08%
04:05PM	Pulmonx Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 04:05PM	Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire) -9.16%
Jul-10-24 04:05PM	Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024 (GlobeNewswire) +13.86%
May-22-24 09:55AM	How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3% (Zacks)
May-06-24 05:03PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.50%
09:55AM	Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High? (Zacks)
May-03-24 09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) +21.50%
07:05AM	Q1 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:38AM	Pulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ... (GuruFocus.com)
May-01-24 08:55PM	LUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:46PM	Pulmonx Corp (LUNG) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Continued Losses (GuruFocus.com)
04:05PM	Pulmonx Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-10-24 04:05PM	Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 (GlobeNewswire)
Apr-02-24 04:05PM	Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer (GlobeNewswire) -6.79% -6.58%
Mar-15-24 05:00PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-29-24 11:35PM	Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
Feb-26-24 08:00AM	Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal Trial (Business Wire)
Feb-22-24 09:55AM	Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript (Insider Monkey) -18.21%
06:56AM	Q4 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:44PM	Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses (GuruFocus.com)
04:06PM	Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
04:05PM	Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer (GlobeNewswire)
Feb-17-24 12:08AM	Insider Sell: President and CEO French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Feb-13-24 01:08PM	PRIMECAP Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
Feb-07-24 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 (GlobeNewswire)
Dec-22-23 11:19PM	Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Dec-11-23 09:00AM	The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors (GlobeNewswire)
Nov-17-23 01:08PM	Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare (InvestorPlace)
Nov-15-23 04:05PM	Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Oct-31-23 04:05PM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire) +11.41%
09:00AM	Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:03AM	Q3 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-30-23 06:30PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:53PM	Pulmonx Corp (LUNG) Reports Record Q3 2023 Financial Results (GuruFocus.com)
04:05PM	Pulmonx Reports Record Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-16-23 04:05PM	Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023 (GlobeNewswire)
Oct-10-23 04:05PM	Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue (GlobeNewswire) -13.36%
Aug-30-23 04:05PM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-02-23 05:55PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 04:05PM	Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire) +7.23%
Jul-19-23 04:05PM	Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023 (GlobeNewswire)
Jul-17-23 08:00AM	Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023 (GlobeNewswire)
Jul-10-23 08:47AM	Shareholders in Pulmonx (NASDAQ:LUNG) are in the red if they invested a year ago (Simply Wall St.)
May-03-23 10:43AM	Q1 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents) +8.63%
May-02-23 05:35PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.90%
04:05PM	Pulmonx Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 08:24PM	7 Nasdaq Small-Cap Stocks Set to Outperform in 2023 (InvestorPlace)
Apr-25-23 04:05PM	Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference (GlobeNewswire) -5.57%
Apr-18-23 04:05PM	Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023 (Business Wire)
Apr-17-23 02:20PM	Pulmonx Corporation (NASDAQ:LUNG) Not Flying Under The Radar (Simply Wall St.) +6.06%
Feb-24-23 04:00PM	Why Shares of Pulmonx Rose This Week (Motley Fool) +5.98%
Feb-22-23 05:55PM	Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +20.21%
04:05PM	Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Feb-16-23 04:05PM	Pulmonx to Present at the Citi 2023 Healthcare Conference (GlobeNewswire)
Feb-08-23 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023 (GlobeNewswire)
Jan-31-23 06:57AM	Pulmonx (NASDAQ:LUNG) investors are sitting on a loss of 66% if they invested a year ago (Simply Wall St.)
Dec-14-22 04:05PM	American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/Emphysema (Business Wire)
Nov-30-22 07:00AM	Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema (Business Wire) +12.73%
Nov-16-22 04:05PM	Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference (GlobeNewswire) -8.61%
Nov-11-22 05:12AM	Pulmonx Corporation (NASDAQ:LUNG) Analysts Just Slashed Next Year's Revenue Estimates By 21% (Simply Wall St.) +14.36%
Nov-09-22 06:27AM	Pulmonx Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.) -7.16%
Nov-04-22 12:34PM	Why Pulmonx Stock Is Crashing Today (Motley Fool) -60.94%
08:00AM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire)
Nov-03-22 06:45PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -9.53%
04:05PM	Pulmonx Reports Third Quarter 2022 Financial Results (GlobeNewswire)

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ferrari Richard	Director	Jun 12 '25	Sale	3.16	8,000	25,280	87,024	Jun 13 05:38 PM
Ferrari Richard	Director	Jun 13 '25	Proposed Sale	3.01	5,438	16,368		Jun 13 11:47 AM
RICH FERRARI	Director	Jun 12 '25	Proposed Sale	3.16	8,000	25,307		Jun 12 05:24 PM
Florin Daniel P	Director	Jun 05 '25	Buy	3.06	23,321	71,362	117,231	Jun 05 08:39 PM
Williamson Steven S.	PRESIDENT AND CEO	Jun 02 '25	Sale	3.13	9,923	31,059	366,115	Jun 04 06:13 PM
Joshi Mehul	Chief Financial Officer & PAO	Jun 02 '25	Sale	3.13	8,061	25,231	213,925	Jun 04 06:10 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Jun 02 '25	Sale	3.13	6,947	21,748	386,331	Jun 04 06:04 PM
Lehman David Aaron	GENERAL COUNSEL	Jun 02 '25	Sale	3.13	10,457	32,736	273,039	Jun 04 06:02 PM
French Glendon E. III	Director	Mar 20 '25	Sale	7.85	20,000	157,000	991,974	Mar 21 06:14 PM
GLENDON FRENCH	Director	Mar 20 '25	Proposed Sale	7.77	60,000	466,200		Mar 20 04:19 PM
Joshi Mehul	Chief Financial Officer & PAO	Mar 03 '25	Sale	7.12	14,384	102,414	113,986	Mar 05 06:12 PM
Williamson Steven S.	PRESIDENT AND CEO	Mar 03 '25	Sale	7.14	27,689	197,699	194,342	Mar 05 06:09 PM
Lehman David Aaron	GENERAL COUNSEL	Mar 03 '25	Sale	7.65	22,355	170,921	175,496	Mar 05 06:04 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Mar 03 '25	Sale	7.13	5,779	41,193	285,278	Mar 05 06:02 PM
DAVID LEHMAN	Officer	Mar 03 '25	Proposed Sale	7.97	13,622	108,569		Mar 03 04:44 PM
French Glendon E. III	Director	Feb 20 '25	Sale	8.28	55,453	459,086	1,011,974	Feb 24 05:50 PM
GLENDON FRENCH	Officer	Feb 20 '25	Proposed Sale	6.64	55,453	368,208		Feb 20 04:22 PM
French Glendon E. III	Director	Jan 16 '25	Sale	6.53	2,326	15,189	1,069,648	Jan 21 05:59 PM
French Glendon E. III	Director	Jan 17 '25	Sale	6.50	2,221	14,436	1,067,427	Jan 21 05:59 PM
GLENDON FRENCH	Director	Jan 17 '25	Proposed Sale	6.40	2,221	14,214		Jan 17 04:18 PM
GLENDON FRENCH	Director	Jan 16 '25	Proposed Sale	6.72	2,326	15,631		Jan 16 04:41 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Dec 02 '24	Sale	6.18	4,376	27,065	291,057	Dec 04 06:18 PM
Lehman David Aaron	GENERAL COUNSEL	Dec 02 '24	Sale	6.19	5,497	34,006	197,851	Dec 04 06:16 PM
French Glendon E. III	Director	Nov 22 '24	Sale	6.63	20,000	132,600	1,071,974	Nov 26 06:33 PM
GLENDON FRENCH	Officer	Nov 22 '24	Proposed Sale	6.42	20,000	128,400		Nov 22 04:28 PM
French Glendon E. III	Director	Oct 17 '24	Sale	6.52	20,000	130,400	1,091,974	Oct 21 05:45 PM
GLENDON FRENCH	Officer	Oct 17 '24	Proposed Sale	6.80	20,000	136,000		Oct 17 04:20 PM
French Glendon E. III	Director	Sep 12 '24	Sale	8.09	20,000	161,800	1,111,974	Sep 18 06:08 PM
GLENDON FRENCH	Director	Sep 12 '24	Proposed Sale	7.75	20,000	155,000		Sep 12 04:32 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Sep 03 '24	Sale	6.70	4,586	30,721	295,433	Sep 05 06:10 PM
Lehman David Aaron	GENERAL COUNSEL	Sep 03 '24	Sale	6.69	5,765	38,576	203,348	Sep 05 06:08 PM
Williamson Steven S.	PRESIDENT AND CEO	Aug 20 '24	Buy	6.84	14,245	97,436	219,531	Aug 22 06:41 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LUNG

Pulmonx Corp

Upgrade your FINVIZ experience